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ABSTRACT
Staphylococcus aureus (SA) is a major human pathogen that colonizes the anterior nares
in 30% of the human population. Though nasal carriage of SA is a known risk factor for the
subsequent spread of SA infections, the dynamics of SA nasal colonization is poorly understood.
Our research focuses on understanding the host and bacterial factors that might contribute to the
human nasal colonization by SA.

In an attempt to elucidate the host response to SA, we

performed an autologous human in vivo nasal colonization study, which showed decreased
survival rates of SA in hosts who elicited a robust immune response. We also identified a
significant correlation between SA nasal colonization and the expression of host
proinflammatory, chemotactic and growth factors.
Additionally, we functionally disrupted a major autolysin, atl a surface expressed
bacterial protein that plays multiple roles in cell separation, adhesion and biofilm formation of
SA. Microscopic analysis of the ∆atl strains showed phenotypic differences, including cell
clumping and cluster formation due to defective cell separation, which confirmed the functional
loss of atl. Subsequent analysis of the ∆atl and wild-type strains revealed that there was no
significant difference in their ability to adhere to human nasal epithelial cells (hNEC) in an ex
vivo hNEC model. Similarly, our competitive in vivo human nasal colonization study, in which
equal colony-forming units of each wild-type and ∆atl SA strain were inoculated in the anterior
nares of donors, showed similar survival rates between wild-type and ∆atl. These results suggest
that Atl might not be directly involved in the adherence and colonization of SA to the anterior
nares. Furthermore, our study suggests that host factors might play a predominant role in
determining SA colonization to human anterior nares.
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CHAPTER 1. INTRODUCTION
1.1 Nasal carriage of Staphylococcus aureus
Staphylococcus aureus (SA) is a gram-positive cocci, that was first clinically observed
and published in 1880 (Lowy, 1998). It is distinguished from other staphylococcal species by its
gold pigmented colonies and by being positive for coagulase, mannitol-fermentation and
deoxyribonuclease test (Kluytmans, van Belkum, & Verbrugh, 1997). Though it is a common
inhabitant of human skin and respiratory tract, SA is a potent pathogen that causes life
threatening community-acquired infections (Ogston, 1882). In addition, with the emergence of
multidrug resistant strains, there has been a steady increase in the mortality rate with SA
infections (Zeller, Burke, & Glass, 2007).
SA predominantly colonizes the anterior nares in approximately 25-30% of the human
population (van Belkum et al., 2009). Nasal carriage of SA is mainly responsible for the
dissemination of nosocomial and community acquired infections that range from mild skin
infections to the most serious forms like endocarditis, osteomyelitis and sepsis (Ogston, 1882).
Therefore nasal carriage is a critical factor responsible for the spread of SA infections and in
United States the death rate due to SA has exceeded that of HIV (Zeller et al., 2007). Though
antibiotics can be used to prevent the nasal carriage, SA effectively re-colonizes within months or
weeks after which antibiotic effect diminishes. The complex nature of pathogenesis coupled
with the emergence of multidrug resistant strains, has raised heightened challenge in the
treatment of SA associated infections (Enright, Day, Davies, Peacock, & Spratt, 2000).
Therefore it necessitates the need for novel strategies to eliminate SA nasal carriage.
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SA has been sampled in various regions in the nose of healthy individuals and its has been
prominently localized to the vestibulum nasi (Cole, Tahk, Oren, Yoshioka, Kim, Park, & Ganz,
2001b). The bacterial load of SA in persistent carriers ranges from 104 to 105 bacteria per nasal
swab (Burian, Wolz, & Goerke, 2010) or upto 108 CFUs in the nasal fluid (Cole, Tahk, Oren,
Yoshioka, Kim, Park, & Ganz, 2001b). The invasiveness of SA as an intracellular pathogen
varies depending on the mammalian cell type and the type of bacterial strain.

Though

intracellular residency of SA has been reported in various cell types it is unknown whether SA
internalizes the keratinocytes during nasal colonization (Plouin-Gaudon et al., 2006).
Based on the nasal carriage patterns of SA in healthy individuals, individuals have been
classified as persistent carriers (persistently carry SA in the anterior nares) and intermittent
carriers or non-carriers (Eriksen, Espersen, Rosdahl, & Jensen, 1995). It has been reported that
SA carriage rate also varies based on age, gender, serum glucose levels and various diseases (van
den Akker et al., 2006). Overall, not all individuals carry SA persistently and also only certain
bacterial clones are more predominant than others, which suggests that both bacterial and host
determinants along with other external stimuli plays a combined vital role in human nasal
colonization by SA.
1.2 Host factors contributing to nasal carriage
The human anterior nares are the primary reservoirs of SA and successful colonization of
SA implicates the adaptation of the pathogen to this milieu (Burian et al., 2010).

The

colonization of SA in the nasal passages is through interaction of bacterial determinants to host
factors (Figure 1). The innate immune response in the nasal secretions is the first line of defense
against the colonized SA. The nasal carrier strains of SA had developed strategies to overcome
2

the host innate immunity by circumventing the host clearance mechanisms namely antimicrobial
peptides, pathogen recognition receptors and the defensive properties of the nasal fluid
(Hashimoto et al., 2006). Epithelial cells detect SA through the pathogen recognition receptors
(PRR), namely Toll like receptors (TLR), and induce the humoral immune system (Ozinsky et
al., 2000). TLR2 works in combination with TLR1 or TLR6 and in case of internalized SA
intracellular nucleotide-binding receptors (NOD2) plays an important role in the recognition of
SA (Fournier & Philpott, 2005). However SA strains are highly resistant to the lysozyme and
lactoferrin due to its peptidoglycan configuration.

(Adapted from Weidenmaier, Goerke, & Wolz, 2012)
Figure 1. SA colonizing the nasal epithelial cells.
Anterior nares that is a part of the vestibulum nasi, that has non-ciliated squamous
epithelium. The apical surface is layered with a mesh of anucleated corneocytes that
expresses various proteins like loricin, involucrin and cytokeratins. These host factors act
3

as interaction partners for the bacterial determinants. ClfB of SA is known to interact
with cytokeratin 10, IsdA mediates adherence of SA through Loricin and Involucrin.
Subcutaneous SA inoculation studies in mice revealed that TLR2 and MyD88 plays an
important role in neutrophil recruitment to the site of infection (Miller et al., 2006). Autosomal
recessive MyD88- and IRAK- patients had recurrent SA skin infections (Picard, Casanova, &
Puel, 2011).

Epidemiological studies have elucidated SA nasal carriage rate in healthy

individuals to be associated with the polymorphisms in host receptors like TLR’s, glucocorticoid
receptors ER22/23EK (van den Akker et al., 2006).
The human nasal epithelium expresses three types of defensins namely human beta
defensin-1 (HBD 1-3). Defensins are a class of cationic antibacterial peptides that are secreted
by nasal epithelia, when it encounters a bacterium, fungi and enveloped virus. It was observed
that HBD-2 is up regulated during infection, which can be induced by the pathogen recognition
receptor Toll-like receptor TLR2, which in turn recruits the neutrophils and expresses host
immune factors to effectively face the bacterial challenge (Figure 2) (Meyer, Harder, Gorogh,
Schroder, & Maune, 2000).

Although there were elevated levels of HBD-2 and human

neutrophils in carriers, it was not sufficient to eliminate and prevent the colonization of SA.
Previous studies in our laboratory have observed that the carrier strain was able to efficiently
surpass the antimicrobial activity of HBD-2 and 3 when compared to the non-carrier strain.
Quinn and colleagues observed that SA delayed the expression of TLR2 by 4hrs and thereby
prevented the expression of HBD-2 and HBD-3. This suggests that SA carriers suppress the host
immune system for a sufficient period of time that enables the colonization of the nasal
epithelium (Quinn & Cole, 2007). The Il-1 significantly inhibited the growth and attachment
ability of the carrier strains than the non-carrier strains of SA (Quinn, Tarwater, & Cole, 2009).
4

Even though IL-1 and Il-1 significantly inhibits the carrier strain in the in vitro studies, the
carrier strains of SA evades the host innate immune system by down regulating the expression of
IL-1, Il-1 and IL-1Ra in the nasal epithelial cells, and thereby the carrier strains take
advantage of the host in colonizing (Quinn et al., 2009).

Adapted from (Johannessen, Sollid, & Hanssen, 2012)
Figure 2. Representation of host immune response to SA components.
The host immune response to SA is mediated by various pattern recognition receptors
(PRR) that recognize various pathogen associated molecular patterns (PAMP’s). Toll
like receptors (TLRs) recognize these PAMPs and thereby activates and recruits various
adaptor proteins like MyD88, TIR etc. Activation of TLRs results in expression of
various cytokines, antimicrobial peptides and other defensive peptides that act as first line
of defense for SA colonization and infections.
SA nasal carriers strains suppressed the TLR2 expression by 4 hr that results in the
downregulation of the host immune defense mechanism and thereby SA carrier strain
successfully colonizes the anterior nares. In contrast to the non-carrier strain, SA carrier strains
5

inhibited the expression of defensins HBD2 and HBD3 (Quinn & Cole, 2007). As one of the
functions of HBD2 is to induce the recruitment of neutrophils, it was found that inhibition of
HBD2 directly hinders the antimicrobial activity. Thus the suppression of immune system
coupled with a wide array of additional virulence factors, makes way for SA to successfully
evade the immune system and result in establishment of SA in nasal epithelial cells. As a result,
studies on both the host and bacterial factors will provide insight of how the nasal colonization is
established by different carrier strains of SA.
1.3 Bacterial factors involved in nasal carriage
SA successfully colonizes the nasal passage by expressing a wide array of virulence
factors, one class of which is the cell surface proteins termed microbial surface components
recognizing adhesive matrix molecules (MSCRAMMs), that causes the pathogen to strongly
adhere to the nasal epithelial cells (Burke, McCormack, Rindi, Speziale, & Foster, 2010). They
are virulence factors which effectively bind to cytokeratins, fibrinogen, fibronectin, laminin,
collagen, vitronectin and thrombospondin to actively promote colonization of SA to host
epithelial cells (O'Brien, Walsh, Massey, Peacock, & Foster, 2002).

Some of these

MSCRAMMs are fibronectin-binding protein A (FnBPA), collagen-binding protein and a
fibrinogen-binding protein, clumping factor A (ClfA), Protein A (Spa) and Elastin Binding
Proteins (Ebps) (McGavin, Raucci, Gurusiddappa, & Hook, 1991).

Specific structural

organization of these bacterial surface proteins facilitates the adherence of SA to the host
epithelial cells. In a similar way there a number of host factors such as IgG, glucocorticoid
receptor and histocompatibility antigen preventing the adherence and colonization to the host
(Foster & Hook, 1998).
6

The cell wall proteins of SA exert their pathogenicity by potentially acting as an
immunosuppressant or affecting the physiological process of the organism (Valisena, Varaldo, &
Satta, 1991). It has been characterized that SA nasal colonization has been characterized by
expression of genes involved in adhesion, immune-evasion and cell surface dynamics
remodeling (Burian et al., 2010). This necessitates the identification of bacterial and host factors
that contribute to the colonization of SA to nasal epithelial cells.
There are 24 surface proteins and 13 secreted proteins present in the genome of SA
responsible for adhesion and immune evasion in host epithelial cells(McCarthy & Lindsay,
2010). The ability of the bacterium to adhere is an important facet required by SA to effectively
interact with the host epithelial cells (Clarke & Foster, 2006). SA expresses microbial surface
components recognizing adhesive matrix molecules (MSRAMMs) on the bacterial surface that
interact with fibrinogen, fibronectin and vitronectin, elastin (ELN), prothrombin (PT) and von
Willebrand factor on the host epithelial cells for colonization (Burke (Burke et al., 2010; Clarke
et al., 2009). Clumping factor B one of the surface expressed protein has been observed to be
strongly associated with nasal colonization in rodents as well as in in vivo cells (Foster, 2009).
Another protein named IsdA, which is responsible for the iron regulation on the squamous
epithelial cells was also observed to promote nasal adhesion of SA to the host epithelial cells
(Foster, 2009). IsdA is reported to protect the SA against the apo-lactoferrin secreted by the host
antimicrobial machinery, thereby overcoming the host immune response (Clarke et al., 2009).
Clumping factor B and the IsdA involvement in nasal carriage has been confirmed by analyzing
the ClfB and IsdA deletion mutants. In both the mutants SA was observed to be defective in
nasal colonization (Foster, 2009).
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Autolysins are surface associated adhesins that initiates primary attachment of SA to
host and host factor coated materials like fibrinogen, fibronectin and vitronectin ((Heilmann,
Hartleib, Hussain, & Peters, 2005). It has been reported that the cell surface dynamics and
remodeling proteins like AtlA, SceD, OatA were prominently expressed during nasal
colonization (Burian et al., 2010). Autolysins are peptidoglycan hydrolases, which are involved
in cell wall turnover, separation and lysis of bacteria induced by beta lactam antibiotics (Biswas
et al., 2006).
Atl is a major bifunctional peptidoglycan hydrolase of SA. It is a 138kDa protein that
undergoes proteolytic cleavage to generate two functional domains namely amidase (62kDa) and
glucoseaminidase (51kDa) domain in the culture supernatant (Takahashi et al., 2002) (Figure 3).
The processed Atl products were reported to surface localize in the septal region thereby playing
a major role for the separation of the daughter cells.

Figure 3. Functional domains of autolysin Atl.
Atl precursor protein is exported to the membrane through N-terminal signal sequence.
Atl is a138kDa protein that is proteolytically cleaved at sites 198 and 775 to generate two
functional proteins 62kDa amidase and 51kDa glucosaminidase as well as the propeptide
(115kDa or 85kDa intermediates).
The deletion mutant of atl has major disadvantage resulting in huge cell cluster formation
due to defective cell separation. However, the atl deletion mutant did not affect the growth rate
of the bacteria as aaa was found to be upregulated and compensate for atl deletion (Biswas et al.,
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2006). aaa is another autolysin which has adhesion/lytic activity, implicated in the colonization
of the host factor coated materials or the host tissue (Heilmann et al., 2005). Though the
upregulation of aaa in the atl deletion mutant was a compensatory role adapted by SA, it did not
alter physiological changes caused by the atl mutation (Biswas et al., 2006). isaA and sceD are
other autolysins that were lytic transglycosylases that play a combined role in multiple functions
like growth separation and cell wall turnover. sceD acts as an indicator for SA to be expressed in
stressful conditions (e.g. at increased salt concentrations). sceD was found to be essential in the
nasal colonization of cotton rats; but its role in the nasal colonization of humans remains to be
elucidated. isaA is another protein which interacts with the cell wall of the pathogen and is
essential for the virulence of the organism (Stapleton et al., 2007). There is a regulatory
feedback mechanism in which inactivation of isaA by an increase in the transcription of SceD.
This was confirmed by increased colonization in the anterior nares of cotton rats (Stapleton et al.,
2007). Therefore, both isaA and sceD are important for the virulence and the adherence of the
bacteria in the host epithelial cells (Stapleton et al., 2007).
Based on previous findings, disruption of autolysin genes might lead us to identify the
role of each autolysin in human nasal colonization. Though there are many previous analyses on
autolysin genes, it was insufficient to delineate the role of autolysin atl specifically in human
nasal colonization. Our study is distinct in analyzing them in the human nasal epithelial cells, an
ex vivo adhesion model for nasal colonization that was developed in our laboratory (Quinn &
Cole, 2007). In addition to the ex vivo model, we also developed an human in vivo nasal
colonization model that helped us to evaluate the host specific innate immune response with
respect to SA nasal colonization patterns. We performed both non-competitive and competitive
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study with the wild-type and atl SA strains. The non-competitive study was instrumental in
elucidating the role of host immune response of donors to their own native wild-type strains and
its correlations to SA carriage patterns. Our competitive human nasal colonization studies in
which equal volumes of wild-type and atl SA strains were inoculated, monitored and
characterized the ability of atl SA strains to compete with wild-type SA strains and colonize the
nasal epithelium. This is the first study, to characterize the role of atl in the autologous in vivo
human nasal colonization model. Even though there were numerous in vitro and animal model
experiments that characterized the role of autolysins in nasal colonization, those were of less
relevance to the human physiological condition. Thus, in addition to developing the in vivo
human nasal colonization model, we also for the first time report some of the SA survivability
trends based on host innate immune response.
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CHAPTER 2. MATERIALS AND METHODS
2.1 Ethics Statement
The Institutional review board (IRB) of University of Central Florida approved the in
vivo nasal colonization study in human volunteers. Written consent was obtained from the
donors before participating in the study. The donors that were involved in the study and their
corresponding strain types are listed in (Table 1).
2.2 Strains, growth conditions and reagents
Bacterial strains and oligonucleotides used in this study are listed in (Table 2). The
strains of E. coli were grown in LB media and plates at 37C. The E. coli strain carrying the E.
coli-SA shuttle vector pNL9164 were grown on LB media and agar plates containing 50g/ml of
ampicillin. The SA strains were grown in either Tryptic soy broth (TSB) or Brain heart infusion
media (BHI) based on the assay. SA nasal isolates transformed with the E. coli-SA shuttle vector
were grown in TSB or BHI media or plates containing erythromycin (50g/ml) at 32C.
Primers used in this study were ordered from IDT (Table 2). Restriction enzymes used
for the cloning of the plasmids were ordered from New England Biolabs (NEB). Ligation
reactions were carried out using Quick-Link T4 DNA ligation kit. PCR was performed using
High fidelity Platinum Taq (Life Technologies) on the genomic DNA’s isolated using
GenElute Bacterial Genomic KitTM (Sigma-Aldrich). Isolation of plasmid DNA from E. coli was
done using Purelink TM HQ plasmid miniprep. Colony PCR from bacterial colony growth was
resuspended in 5l of double-distilled H2O and then used as template for the PCR. The PCR
conditions were optimized in addition to manufacturers recommendations.
11

2.3 Experimental in vivo SA nasal inoculation protocol
12 healthy donors (6 men and 6 women) who were carriers of SA were involved in the
study. The donors were decolonized with topical application of mupirocin, twice each day for 5
days. A period of 8 days was given to permit the commensal microbial flora to recover in their
anterior nares. The donors were then prescreened before inoculation to confirm the absence of
SA strains and were inoculated with 2*107 colony forming units (CFUs) of wild-type donor
specific nasal isolates. Post inoculation the donors were regularly swabbed and nasal fluid was
collected at regular intervals.

The right and the left anterior nares were swabbed using

polystyrene cotton swabs and re-suspended in 2ml of TSB, from which dilutions were plated on
Blood agar plates (TrypticaseTM Soy Agar with 5% sheep blood). The nasal secretions were
assayed for cytokines using Bioplex

TM

analysis, below. The nasal secretions were collected

using suction catheters that are vacuum aided method and stored at -80 C until processing for
cytokine analyses (Cole, Tahk, Oren, Yoshioka, Kim, Park, & Ganz, 2001a). We also did
competitive studies, in which we inoculate equal volumes of wild-type and atl SA nasal isolates
and assess the ability of atl SA to compete and colonize with the wild-type strains (protocol to
describe atl is described below). The detection of wild-type and atl SA strains were detected
using colony PCR using primers (Table 1) that will confirm the 900 bp intron insertion in the
mutant SA strain.
2.4 Detection of 27 immune response mediators in nasal fluid secretions
Cytokines, chemokines and growth factors associated with subclinical inflammation were
analyzed in nasal fluids from both wild-type and competitive in vivo human nasal colonization
studies, in order to understand the host immune response with respect to SA nasal colonization.
12

The nasal fluids obtained from the donors using vacuum aided suction method were microtip
sonicated for 3s and spun down to remove the debris. The volume of the total nasal fluid
collected was noted before sonication in order to calculate the concentration of the cytokines
expressed per donor. A panel of 27 cytokines was assessed from the clarified nasal fluid using
multiplex enzyme-linked immunosorbent assay (Bioplex 200 system, Bio-Rad Laboratories, Inc.,
Hercules, CA) that employed simplified magnetic bead based plate processing. The clarified
nasal fluids were loaded on low binding 96 well plates and were processed according to the
manufacturer’s instructions to perform.
2.5 Retargeting the Ll.LtrB intron and creating insertional mutation in the atl gene
Based on the sequence of the target gene, the TargeTron algorithm (www.sigmaaldrich.com/targetronaccess) identifies the potential intron insertion sites and designs PCR
primers to retarget the intron RNA’s (Exon binding sites 1 &2) EBS1, EBS2 and  (sequence
adjacent to EBS1) sequences to base pair with the target site (Intron binding sites 1 & 2) IBS1,
IBS2 in the 5’ to 3’ exon and ’ near the 3’ exon site. The 350bp intron template was retargeted
using these PCR primers. The retargeted amplicon was restriction digested with HindIII and
BrsG1 and cloned into the same restriction digested pNL9164 E. coli-SA shuttle vector (Figure
4). The pNL916429a was cloned in DH5 E. coli and pNL916490s and pNL9164109a were
passaged in DC10B dcm- E. coli. The plasmids were electroporated into their corresponding SA
nasal isolates and then plated in BHI plates containing 50g/ml erythromycin at 30C. Resulting
colonies were screened for intron insertion and the plasmid was cured overnight at 43C. The
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plasmid free colonies were identified by plating them in BHI (no antibiotic) and BHI plate
containing erythromycin simultaneously.

Figure 4. pNL9164 Intron-donor plasmid.
pNL9164 is an E. coli-SA shuttle vector that that uses a cadmium inducible promotor
with a regulator to express the LI.LtrB-ORF intron. The plasmid carries both
staphylococcal pT181 replicon and colE1 replicon. It has erythromycin-resistance
(ermC) and ampicillin-resistance (ampR) genes for selection in both SA and E. coli. For
targeted intron insertion, EBS1, EBS2 and  sequences are made complimentary to IBS1,
IBS2 and ’sequences in the target gene of interest.
2.6 Transmission Electron Microscopy
Overnight SA cultures that were washed twice in 0.1M phosphate buffer and fixed with
2.5% glutaraldehyde were sent to Interdisciplinary Center for Biotechnological Research (ICBR)
at the University of Florida for Transmission electron microscopy (TEM). The fixed SA cells
were processed in Pelco Biowave laboratory microwave. The samples were then washed with
0.1M sodium cacodylate ph7.4 and fixed with 2% buffered osmium tetroxide. The fixed SA cells
were washed with water and dehydrated in graded ethanol series 25%, 50%, 75%, 100% and
14

followed by 100% acetone. The dehydrated samples were permeated in Spurrs epoxy resin and
cured at 60ºC. Cured resin blocks were trimmed, thin-sectioned and collected on Formvar copper
grids. The thin sections were then stained with 2% aqueous uranyl acetate and Reynold lead
citrate. Sections of SA embedded resin were examined with Hitachi H-7000 TEM and digital
images were acquired using Veleta 2000 * 2000 camera and iTEM software.
2.7 Whole-cell Autolysis assay
The whole cell autolysis assay was adapted from the previous protocol (Bose, Lehman,
Fey, & Bayles, 2012). 50ml of log phase cultures of SA were grown to an O.D of 0.7 at 600nm.
Once the O.D. is reached the cells were chilled immediately on ice for 15 min and spun down at
10,000g for 15mins. The supernatant was discard and the cell pellets were washed with ice cold
ddH2O at 10,000 g for 15mins. The washed cells were resuspended in 25ml of 0.1% Triton-X
(pH 7.0) and brought to an initial O.D of 1. The triton-X re-suspended cells were incubated at
37ºC at 250rpm. Every 30 min 1ml of the culture was drawn in 2ml cuvettes and the readings
were taken for 4 hours using Thermo Spectronic Biomate 3 spectrophotometer. Cell lysis was
measured as decrease in O.D. at 600nm.
2.8 Zymogram analyses of autolysins
SA was grown in 50ml of TSB for 6 hours at 37C, 250rpm and was sedimented at 5000g
for 15mins. The pellets were re-suspended in 125mm-Tris SDS buffer for 10µl/mg of SA cell
pellets. Cell pellets re-suspended in the buffer was heated at 95ºC for 3 min and centrifuged at
13000rpm for 3 min. The supernatant was collected and approximately 15mg/ml of protein was
loaded in 8% SDS-tricine PAGE gel embedded with M. luteus. The protein concentration was

15

determined using BioRad protein BCA assay. M. luteus acts as a substrate for peptidoglycan
hydrolases. After electrophoresis the gel was washed in ddH2O and overnight renaturation was
performed in 100mM phosphate buffer at pH 7.0. The renatured gel was washed twice with
ddH20 and then stained with 4% methylene blue at 4ºC for 1hr. The gel was de-stained with
ddH2O for 1hour to observe the zone of clearance that represents the peptidoglycan hydrolysis
activity.
2.9 Growth Kinetics assay
Bacterial growth kinetics of both wild-type and atl SA strains were determined by CFU
assay. The wild-type and the atl SA nasal isolates were grown to log phase in trypticase soy
broth (TSB) at 37°C at 250rpm. SA was diluted again in fresh pre-warmed 5ml of TSB and
D0.05 (Dulbecco’s modified Eagle’s minimal medium with glucose (4.5g/liter, L-glutamine (584
mg/liter), and sodium pyruvate (110mg/liter) supplemented with 5% (vol/vol) fetal bovine serum
(FBS media to approximately 105 CFU/ml. The assay was carried out in both nutrient rich media
(TSB) and Minimal media (D0.05) to observe if there is any difference in growth kinetics due to
the supplements in the medium. Dilutions of the culture were plated on Trypticase soy agar
plates at 0, 3, 6, 9 and 24 hours. The plates were incubated for 16 hours after which the
corresponding CFU counts were enumerated. CFU counts over the time points represent the
growth rate of SA nasal isolates.
2.10 Ex vivo adhesion assay
Human Nasal Epithelial Cells (NEC’s) (RPMI 2650, American Type Culture Collection,
Manassas,VA) were grown on collagen coated transwells (Transwell® 12-mm, 0.4µm pore size;

16

Corning Inc., Corning,NY).

D10 (Dulbecco’s modified Eagle’s minimal medium with

glucose(4.5g/liter, L-glutamine (584 mg/liter), and sodium pyruvate (110mg/liter) supplemented
with 10% (vol/vol) fetal bovine serum(FBS: Gemini Bioproducts, West Sacramento,CA)),
Penicillin (100 U/ml), and streptomycin (100µg/ml). Cells were grown at 37ºC with CO2 and the
antibiotic media was replaced regularly until they reach their confluence.

Following their

confluence, the NEC’s were exposed to air-liquid interface for 4 days and cultured regularly with
antibiotic free media before starting the adhesion assay (Figure 5). 103 CFU’s of SA was
inoculated on the NEC’s and at regular intervals the growth kinetics and the adherent levels were
measured. The apical surface of the NEC’s were washed with 500µl of D10 medium for 3 times
and plated at appropriate dilutions. This wash fraction will represent the growth kinetics and the
non-adherent SA. The scraped NEC’s were sonicated and plated at regular intervals that will
represent the adherent SA.

Figure 5. Ex vivo human nasal adhesion model.
Human nasal epithelial cells were grown to confluence on 0.4 m pore size transwells
and were exposed to air-liquid interphase to mimic the physiological environment in the
anterior nares.
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2.11 Human beta defensin-3 susceptibility assay
In order to determine the susceptibility of the wild-type and atl SA nasal isolates to
human antimicrobial peptides like HBD-3 we performed the CFU microassay. Cells were grown
to log-phase in TSB media after which its reconstituted to 105 CFU/ml in Dulbecco’s modified
Eagle’s minimal medium with glucose (4.5g/liter, L-glutamine (584 mg/liter), and sodium
pyruvate (110mg/liter) supplemented with 0.05% (vol/vol) fetal bovine serum (FBS: Gemini
Bioproducts, West Sacramento,CA). The susceptibility reactions were prepared by incubating
4µl of bacterial dilution with 1µl of vehicle and appropriate concentration of HBD-3 peptide (10,
20 and 40µm). The assay was carried out in Terasaki plates and the sample wells were coated
with 3µl liquid wax in order to prevent the evaporation while incubating at 37ºC with 5% CO2.
2.12 Biofilm Assay
The biofilm forming capacity was determined by growing wild-type and atl SA strains
on 96-well plates in TSB media. After 24 hours, the plates were processed and stained with 2%
crystal violet.

The plates were incubated for 1 hour and processed.

The change in O.D

represents the amount of bacteria adhered to the plate.
2.13 Etest
Antibiotic susceptibility of SA was performed using Etest gradient antibiotic strips.
Overnight bacterial cultures were re-suspended at 1:100 dilution in fresh prewarmed TSB. The
fresh SA cultures were grown to an O.D of 0.7 and were plated on Mueller Hinton agar plate and
the Etest strip (Etest® bioMerieux) that comprise of stable gradient of antibiotic concentrations
were applied over the MHA plate. The plates were incubated for 18hrs and the minimum
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inhibitory concentration (MIC) of these antibiotics were read. The point of intersection of the
elliptical zone of clearance on the Etest strip represents the MIC.
2.14 Statistical analysis
All the statistical analyses were done using Graphpad Prism (GraphPad Software). Mean
values of the experiments were compared using either one-way ANOVA or two-way ANOVA
and post Bonferroni test was done for comparison of multiple values. P value <= 0.05 were
considered statistically significant and are represented as *. Students t test was used to analyze
the MIC and lysis percentage in the Etest and Autolysis assay. The CFU values from growth
kinetics, ex vivo adhesion and in vivo experiments were normalized by log10-transformation.
Two-way ANOVA was done to compare the differences in growth kinetics in CFU assay and
level of adhesion ex vivo adhesion assay. The correlation of the cytokine values from the nasal
fluid with CFUs was done using Deming regression analysis and Spearman correlation. Kaplan
Meier survival curves were plotted to determine the survivability of SA in the anterior nares for
the in vivo human nasal colonization studies.
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CHAPTER 3. RESULTS
3.1 Nasal carriage status of the donors before SA inoculation
11 donors participated in the human in vivo nasal colonization study did not encounter
any adverse effects. Before the start of the mupirocin treatment the donors were screened for SA
carriage and care was taken that none of the donors were under any other antibiotics. After 8
days post mupirocin treatment the recovery of other non SA endogenous microbial flora was
confirmed. The donors who carried SA after the topical antibiotic treatment were given another
round of 5 days mupirocin treatment.
3.2 SA nasal colonization kinetics in response to host immune response
The difference in carriage patterns of SA in the anterior nares is dependent on multiple
factors. Historically, studies have been done in murine models to determine the kinetics of SA
adhesion to anterior nares with respect to host adaptive immunity; however the biological
relevance of these studies is in question largely because, mice and rats are not naturally
colonized by SA in their nares, nor do their immune systems accurately model the human
condition.

Therefore, in concert with other members in our laboratory (Gowrishankar

Muthukrishnan and Amy. L. Cole, Ph.D), we designed an in vivo human nasal colonization
model to elucidate the role of host immune response in determining the carriage pattern of SA in
the human nose. 11 human donors and a total of 26 inoculations were involved in this study.
Based on optimization we inoculated each donor with 2*107 CFUs of donor specific wild-type
SA strains. Post inoculation the donors were regularly swabbed to enumerate the carriage rate of
SA and the nasal fluid was collected to elucidate the host innate immune response using Bioplex.
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Analysis of 27 immune response mediators in the nasal fluid immensely helped us to understand
the association between the immunological state of the host and SA carriage pattern.
Based on these 27 cytokine values, we represented them as heatmaps (Figure 6). Each
heatmap is a color-coded gradient representation of expression of cytokines normalized to Day 7 (i.e. baseline, prior to experimental SA inoculation). Subsequently, we segregated the donors
into high (positive) immune and low (negative) immune response studies based on score values.
Score values are sum total of the log value of the Day-7 normalized cytokines. Interestingly, the
Kaplan-Meier survival curves between these segregated immune response studies showed that
there was a rapid clearance of SA in donors that elicited higher (Positive value) response but
however there was an increased survivability of SA in donors that elicited (Negative value)
immune response.
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A

B

Figure 6. Decreased survivability of SA in anterior nares when the host elicits higher host
immune response in the nasal secretions.
Heatmaps represent the color-coded gradients of cytokine values normalized to Day -7
(prior artificial inoculation). A) Prolonged survival of SA in a study (D831 n=2) with
lower (Negative score value, Score value= -19.96) immune response. B) Decreased
survival of SA in a higher (Positive score value, Score value= 145.93) immune response
study (D547 n=2). Shades of green represent the fold decrease and shades of red
represent fold increase of cytokines with respect to Day -7. The numbers inside the box
represent the cytokine values expressed as ng/donor.
3.3 Survival of SA with respect to positive and negative immune response donors
From all the 26 in vivo inoculation studies, we characterized them as studies with positive
and negative immune response based on the score value of the 27 immune response mediators
(Figure 7).

The survival curves plotted between these immune response studies showed

significant difference in the survivability with a p value below 0.05. When the host elicited
higher immune response at the time of inoculation, there was a rapid decrease in survival of SA,
with a mean survival of 13.5 days. However when the host immune response was lower at the
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time of inoculation, there was a prolonged survival of SA, with a mean survival time of 28.7
days.

A

B

Figure 7. Lower mean survival of SA in donors with higher host immune response
A. Kaplan-Meier Survival curve represents decreased survivability of SA in high
(Positive score value) response studies. B. Mean survival plotted showed an average of
13.5 days survival period in high (Positive score value) and 28.7 days low (Negative
score value) response donors. Data represents the cytokine values of 12 positive response
and 3 negative response in vivo inoculation studies. ** indicates p < 0.05.
3.4. Significant correlation of host immune response mediators to SA nasal colonization
To help determine the role of these up regulated cytokines to SA nasal carriage we
performed a Deming regression and Spearmann correlation analyses to correlate the CFU values
of SA to the concentration of cytokine expressed by the donor. The analysis was therefore based
on the assumption that data does not assume any distribution of values, as both CFU values and
the immune response values were independent variables. A panel of 27 host immune factors
were analyzed, out of which 9 immune response mediators Il-1, Il-6, IL-7, Il-8, MCP-1, MIP1, MIP-1 and GCSF showed significant positive correlation (p < 0.05) in their level of
expression to the SA carriage rate (CFU values) only in donors that showed positive response
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with r value ranging from 0.24 to 0.3 (Figure 8). However, none of these immune response
mediators showed any significant correlation to SA nasal carriage rate in studies that elicited
negative immune response (not shown).

Figure 8. Positive correlation of host immune response mediators to SA nasal carriage in donors
with higher immune response.
Deming regression analyses show a significant correlation between SA nasal carriage and
various immune response mediators including proinflammatory, chemotactic and growth
factors. Shown are representations of nine immune response mediators among the 27
cytokines analyzed in the nasal fluid that showed significant p and r values and thereby
correlate to the SA carriage rate in the in vivo human nasal colonization studies. The
results are based on 12 inoculation studies that elicited positive immune response.
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3.5 Functional disruption of atl using Targetron gene knockout method
We simultaneously worked on understanding the role of bacterial autolysin Atl in human
nasal colonization. Reports have been made that atl is strongly expressed in SA strains during
nasal colonization and atl strains were defective in biofilm formation. Based on these reports
we hypothesized that Atl might paly a role in human nasal colonization. Since the autolysin Atl,
proteolytically cleaves into two enzymatically active domains amidase and glucosaminidase
domains.

Studies were done previously on these atl SA strains and have been well

characterized the in vitro aspects.

Nevertheless, no studies have been performed on

characterizing the role of atl in human nasal colonization.
We functionally disrupted the atl using Targetron gene knockout method that is based on
the Lactococcus lactis group II introns, that was retargeted to knockout the atl gene in the SA
nasal isolates (Figure 9). We successfully transformed the pnL916429a plasmid directly in D201998 strain and disrupted the atl gene with 100% efficiency. However, our transformations in
D547-14 and D20-24 SA nasal isolates continuously failed. It was recently reported that SA
clinical isolates prevent transformation of E. coli derived plasmids due to robust restrictionmodification. The main restriction system that was responsible for preventing the transformation
was Type IV modification system termed SauUSI. It recognizes the cytosine methylated DNA
derived from DH5 and thereby restricts its entry into SA (Monk, Shah, Xu, Tan, & Foster,
2012). Monk et. al recently created a dcm mutation in the E. coli high efficiency cloning strain
DH10B and termed it as DC10B. We therefore used the plasmids passaged through DC10B for
transforming the pNL916490s & pNL9164109a into D547-14 and D20-24 nasal isolate. We also
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targeted the insertion site in the pre-protein domain at 305 & 388 nucleotide position and thereby
functionally disrupted the entire atl gene from being transcribed.

Figure 9. Confirmation of 900bp intron insertion in the pre-protein domain of atl gene.
The pNL9164 plasmid re-targeted for the SA nasal isolates expresses the RNA protein
complex that specifically inserts into the atl gene. Intron insertion was targeted to the
pre-protein region at around 305,388 bp in D20, D547-14 and D20-24 nasal isolates.
3.6 Phenotypic differences of atl SA
When the atl SA strains were grown overnight, in 96 well plates without shaking it
resulted in cell clumping whereas the wild-type remained as homogenous culture (Figure 10).
This is due to the fact that atl is involved in separation of daughter cells and therefore disrupting
the atl results in defective cell separation that corroborates with cell clumping of atl SA.
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Figure 10. Cluster formation of atl SA strains due to defective separation of daughter cells
Phase contrast microscopy and transmission electron microscopy showing the cluster of
cell aggregates that was formed due to incomplete cell separation of daughter cells (lower
panels). These phenotypic changes are due to defective cell separation of daughter cells
in atl SA strains. (Wild-type – Top panels & atl SA –Lower panels).
The observed cluster formation of atl SA facilitated to confirm that Atl was functionally
disrupted and hence the defective cell separation of SA. Since Atl is involved in processing of
the peptidoglycan layer, disrupting Atl resulted in thicker peptidoglycan layer. The percentage
increase in cell wall thickness varied among the D20, D547-14 and D20-24 strains as 30%,
16.4% and 1.7%. This might be due to the strain specific differences of the cell wall thickness
and contribution of atl in processing of the cell wall. Even though there was an increase in the
cell wall thickness of the atl SA, it did not change the overall surface volume as atl SA (not
shown). The atl SA nasal isolates were slightly smaller than the wild-type and thereby did not
confer any change in the volume of atl SA.
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Since Atl is involved in biofilm formation, we performed static biofilm assay in which
atl SA showed significant decrease in biofilm formation in both D20 and D547-14 nasal isolates
(Figure 11). Though the biofilm formation capacity was reduced in atl D20-24 strains it did
not show any significant difference with the wild-type SA strains. Based on the phenotypic
difference of atl SA cluster formation and biofilm negative phenotype, we confirm that the
function of Atl has been efficiently disrupted using TargeTron gene knockout method.

Figure 11. Decreased biofilm formation in atl SA strains.
The quantified crystal violet reading at 590 nm indicates the adherent biofilms on the 96
well plates. Data represents the average of triplicate experiments with standard error and
mean. * indicates p < 0.05.
3.7 Analyzing the peptidoglycan hydrolase activity between wild-type and atl SA
To analyze the activity and expression of other autolysins in the wild-type and atl SA
nasal isolates, we performed standard zymographic analysis with M. luteus as substrate. It is
known that Atl undergoes proteolytic cleavage to generate 62kDa amidase and 51kDa
glucosaminidase as well as the propeptide (115kDa or 85kDa intermediates) (Biswas et al.,
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2006).

The extracellular proteins extracted at mid-exponential phase showed multiple Atl

associated bands in wild-type SA strains but clearly these bands were missing in the atl SA
strains (Figure 12).

Since activity of autolysin Aaa are very specific to SA, we used SA

embedded zymographic gels and observed an extra band of 32kDa specific to autolysin Aaa in
both wild-type and atl SA. This also confirms that functional disruption of Atl did not alter the
expression of other autolysin Aaa.

Figure 12. atl SA strains shows reduced murein hydrolase activity.
Zymography of wild-type and atl SA strains on M. luteus and SA strains embedded in
8% SDS-tricine gel that are used as substrates. The dotted arrows represesnt bands that
are intermediate products of Atl and the block arrows represent the bands corresponding
to amidase and glucosaminidase were observed only in the wild-type SA. In the second
gel picture, the activity of Aaa autolysin is shown blocked arrow at 35kDA in both wildtype and atl SA strains.
3.8 Effect of functional diruption of Atl on autolysin activity
In order to examine the autolysis activity between the wild-type and atl SA strains we
performed whole cell autolysis using Triton-X. The atl SA strains exhibited decreased autolysis
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activity when compared to the wild-type strains, that is calculated based on the decrease in O.D.
at 600nm (Figure 13). There was a significant decrease in autolysis activity between wild-type
and atl SA in the strains D20 and D20-24. There was no difference in the lysis of D547-14
strain of SA, however 547-14 atl SA followed the same trend of decreased lysis when compared
to wild-type strain. This shows that the functional disruption of atl results in decreased autolysis
activity, but the lysis percentage varies based on the strain specific characteristics.

Figure 13. Decreased autolysis activity of atl SA to Triton-X induced lysis.
Triton-X-100 induced whole cell lysis of wild-type and atl SA of D20, D547-14 and
D20-24 in 50mM tris phosphate buffer at pH7. Data is represented based on experimental
triplicates with standard error and mean. * indicates that p < 0.05.
3.9 Growth kinetics studies of atl SA and wild-type nasal isolates
Since Atl is involved in cell separation of the daughter cells, we examined the effects of
functional disruption of Atl in all 3 different nasal isolate. Despite Atl’s role in cell separation,
we did not observe any significant change in growth kinetics in our CFU assay (Figure 14). We
performed the CFU assay in both nutrient rich media (TSB) and minimal media (D0.05) to
examine if growth kinetics remains the same irrespective of the nutrient supplements in the
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media. Similar growth kinetics was observed between the wild-type and atl SA nasal isolates.
However, atl showed a trend that it has lower growth rate than that of wild-type strains.

Figure 14. atl SA did not show any difference in growth rate when compared to wild-type SA.
SA nasal isolates in both nutrient rich (TSB) media and minimal (D0.05) media. The
culture was drawn and regular intervals with appropriate dilutions at 3, 6, 9 and 24hr to
enumerate the CFUs. The CFUs are represented in log10 transformed and the data
represents of triplicate experiments with standard error and mean.

31

3.10 Ex vivo nasal adhesion model to evaluate the adhesion level of atl SA
SA successfully colonizes the nasal passages based on the adaptation to the donors nasal
secretions and evading other host factors. In order to test the adhesion ability of SA in a more
relevant physiological condition we performed an ex vivo adhesion assay on human nasal
epithelia. Atl has been reported to play a significant role in initial attachment of SA to host and
host factor coated materials. Here, we examined whether functional disruption of atl affects the
colonization efficiency of the atl SA nasal isolates. We used a human nasal epithelial cell
model exposed to air-liquid interface, on which we inoculated 103 CFUs of wild-type or atl SA
nasal isolates. The assessment of the bacterial adherence was done as outlined in the Materials
and Methods. We observed a similar level of adhesion and growth kinetics between the wildtype and the atl SA nasal isolates D20, D547-14 and D20-24 on the nasal epithelial cells
(Figure 15).
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Figure 15. Similar adhesion and colonization ability of atl and wild-type SA in our ex vivo
nasal adhesion model.
Growth and adhesion level of SA nasal isolates D20, D547-14 and D20-24 were assessed
on monolayers nasal epithelial cells grown on air-liquid interphase. 103 of SA was
inoculated on the nasal epithelia to assess the growth kinetics and colonization ability.
The NECs were washed, scraped and plated at regular intervals on TSA plates to
enumerate the CFUs. Panel A represents the wash fraction and panel B represents the
adherent fraction. N=4 data represented as mean +/- SEM.
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3.11 Decreased susceptibility of atl SA to cell wall acting antibiotics
Since Atl was involved in -lactam induced lysis of bacteria, we examined the
susceptibility of these cell wall acting antibiotics on the atl SA strains. We determined the
MICs of both the wild-type and atl strains using an Etest. Etest strips containing a gradient of
antibiotics, were placed on Mueller Hinton agar plates that were coated with a lawn of separate
wild-type and atl SA. The readings of MICs read after 18hr showed that atl D20-98 has
significantly decreased susceptibility to cell wall acting antibiotics like Ampicillin, Daptomycin,
Oxacillin and Benzylpenicillin (Figure 16). In the case of D547-14 and D20-24 atl showed a
significant difference in susceptibility only with Ampicillin, but however we observed a similar
trend of decreased susceptibility with respect to Daptomycin, Benzylpenicillin, and Oxacillin.
These difference in the susceptibilities to antibiotics might be strain specific but however the
overall increase in resistance towards the -lactam antibiotics, confirms the absence of Atl to
mediate the -lactam induced lysis.
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Figure 16. Decreased susceptibility of atl SA strains to cell wall acting antibiotics.
Etest gradient strip of antibiotics were applied on SA inoculated agar surface. After
incubation the bacterial growth becomes visible along the inhibitory ellipse and the
intersection of the ellipse with the Etest strips represents the minimum inhibitory
concentration values of the antibiotics (MIC). MICs values for wild-type and atl SA
nasal isolates in D20, D547-14 and D20-24. The values are based on experimental
triplicates with standard error and mean. * indicates p < 0.05.
3.12 Susceptibility of atl SA to Human beta defensin-3
To elucidate if atl exhibits similar resistance to antimicrobial peptides expressed in the
human nasal fluid, CFU microassays with human beta defensin-3 HBD-3 were performed. As
shown in the (Figure 18) HBD-3 was highly effective at 40M, killing both wild-type and atl
nasal isolates in D20 and D547-14, but atl D20-24 survived even at 40M concentration. In
D20 the wild-type strains was killed at both 20 and 40m molar concentrations of HBD-3. In
the case of D547-14 both wild-type and atl SA survived at 20M concentration of HBD-3
showing no difference in their susceptibility. In summary, there were strain specific variations
that contributed to the difference in susceptibility of SA, but howerver there was a trend of
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decreased susceptibility of atl SA nasal isolates to HBD-3. This result concurs with the
observation of increased resistance of SA to cell-wall acting antibiotics (Figure 17).

Figure 17. Increased resistance of atl SA to human beta defensin–3.
Shown are the bacterial growth rate of wild-type and atl SA nasal isolates D20, D547-14
and D20-24 with HBD-3 at 10, 20 and 40M concentrations. The results here represent
experimental triplicates with standard error and mean. * indicates p < 0.05.
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3.13 Survival of wild-type and atl SA strains in the anterior nares
In our competitive in vivo human nasal colonization study, the donors were inoculated
with equal CFUs of wild-type and atl SA strains and screened for their carriage rate. The
survival curves showed that there was no significant difference in the median survival of wildtype and atl SA strains in the anterior nares. The wild-type and atl SA strains were screened
and confirmed using colony PCR. The survival curves were plotted with singular comparison of
each nostrils as separate experiments. A total of 3 donors were involved in the study and the
results are based on 12 separate nostrils considered as repeat of measures.

Mean survival of WT and atl SA

Figure 18. Similar survival rates of wild-type and atl SA strains were observed in our
competitive human in vivo nasal colonization study.
Kaplan-Meier survival curves showed no significant difference in the survivability of
wild-type and atl SA. Data represents a total of six in vivo human nasal colonization
studies performed in D20, D547 and D20-24. No significant difference were observed
between the survival of wild-type and atl SA.
Our competitive in vivo nasal colonization study did not exhibit any difference in the
survival between the wild-type and atl SA strains (Figure 18). Even though there was a trend
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that atl SA was surviving better than the wild-type there was no significance difference. In
addition to our competitive studies, we also performed n=1 non-competitive in vivo nasal
colonization studies (Figure 19). It showed that atl SA strains tend to survive better than the
wild-type strain. In the future, it would be interesting to repeat the study in different donors to
determine the differences, if any, between the competitive and non-competitive experimental SA
inoculation studies. In the future, it would be interesting to repeat the study in different donors
to determine the differences, if any, between the competitive and non-competitive experimental
SA inoculation studies.

Figure 19. A trend of prolonged survival of atl in the anterior nares was observed in our noncompetitive in vivo nasal colonization study.
The wild-type and atl SA strains were inoculated separately and the CFUs enumerated
showed a trend that atl SA survived better than the wild-type SA in the anterior nares.
This data is a representative of n=1 study with D20 WT & atl SA in the D20 donor.
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CHAPTER 4. DISCUSSION
Nasal carriage of SA is a complex mechanism that involves both bacterial and host
factors. In order for SA to successfully colonize the nasal passages it must adhere to the nasal
epithelial cells and evade the host immune system. Historically various bacterial determinants
(ClfB, WTA, fibronectin binding proteins) and host factors (TLR2, MyD88, loricin,
Cytokeratin10) role in nasal colonization have been studied. There were studies that reported the
autosomal recessive MyD88 and TRIK individuals have increased SA nasal carriage and SA
associated infections (Miller et al., 2006). Studies have shown that intermittent carriers have
higher antibody titer level for SA than the non-carriers (van Belkum et al., 2009). The link
between SA carriage status (persistent and intermittent carriers) and the serum antibody level
aided in understanding the role of host adaptive immunity in determining SA nasal colonization.
Murine nasal colonization models showed that the nasal clearance of SA is T-cell mediated and
IL-17 governed the neutrophil influx that controls the SA colonization (Archer, Harro, &
Shirtliff, 2013).
Previous human nasal colonization studies had various limitations either by using lab
strains or random carrier strains, that might not be a perfect mimic of host response ounted
against these different SA strains. Also the murine and mice models utilized for SA colonization
studies were of less physiological relevance when compared to human nasal colonization
models.

Therefore, it was necessary to develop an appropriate and reliable human nasal

colonization model that might serve as an optimum model to understand these different SA
carriage patterns and host immune response.

We developed an autologous human nasal

colonization model in which we inoculate donor-specific SA nasal isolates in the anterior nares.
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Since nasal fluid was the first line of defense against SA nasal colonization, we assessed a panel
of 27 host immune response mediators expressed in response to SA nasal colonization. Previous
analyses of nasal fluid have characterized that carrier strains evades the host immune response by
suppressing the expression of IL-1 on the nasal epithelial cells (Quinn et al., 2009). IL-1 was
shown to play an important role in inhibiting the growth of nasal carrier strains and thereby play
an important role in determining the nasal carriage of SA (Quinn et al., 2009). Quinn et. al.,
reported that carrier SA strains suppresses the activation of TLR-2 by 4 hr and thereby makes the
carrier nasal fluid defective in killing SA strains (Cole, Tahk, Oren, Yoshioka, Kim, Park, &
Ganz, 2001a).
In this human in vivo nasal colonization study, we elucidate for the first time the different
SA carriage patterns to be associated with the host immune response factors expressed in the
nasal fluid (Figure 6). The Bioplex analyses of the 27 cytokines gave us tremendous insights of
the host immune response with respect to nasal colonization by SA. Clearance of SA from the
anterior nares was found to be associated with higher immune response of the donors at the time
of artificial inoculation whereas there was a prolonged survivability of SA in donors with lower
immune response at the time of inoculation (Figure 7).
In addition, we also characterized the 26 in vivo inoculation studies, as positive response
studies and negative response studies based on the score value, that is sum total of the log
transformed fold change values of cytokines. Based on this immune response characterization,
we found that there has been a significant correlation between nine of the 27 pro-inflammatory,
anti-inflammatory and other immune mediators to nasal carriage by SA only in the studies when
the donors responded with positive immune response (Figure 9). In addition, the Kaplan Meier
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survival curve showed a decreased survivability of 13.5 days in only donors who elicited positive
response at the time of inoculation. These results therefore confirm that host immune response
plays a predominant role in determining the carriage status of SA.
Previous studies in our laboratory have confirmed that the carrier strains have a
significant advantage towards colonization by suppressing the expresiion of host immune factor
IL-1.

Mice colonization studies with ClfB deletion mutant has shown that ClfB can be

considered as one of the major SA associated nasal carriage determinant. Similarly, SdrA was
another adhesion that plays an important role in attachment of SA to the host tissue. However a
high dose of nasal inoculation with ClfB- was shown to overcome the effects of ClfB deletion
(O'Brien et al., 2002).

In order to understand the role of the bacterial determinant, we

specifically chose to characterize the role of these autolysin / adhesin Atl in human nasal
colonization. Functional disruption of autolysin Atl resulted in characteristic phenotypic changes
like cluster formation and cell clumping due to defective daughter cell separation (Figure 11).
Since Atl is known to be involved in biofilm formation, we observed decreased biofilm
formation in atl SA strains (Figure 12). We also observed a significant decrease in the autolysis
activity and susceptibility to cell wall acting antibiotics in the atl SA strains (Figure 13). Based
on these phenotypic changes, we examined the fitness of atl SA strains in comparison to the
wild-type SA strains to colonize the anterior nares, by our competitive in vivo human nasal
colonization study. However, we did not observe any significant difference in the ability of atl
SA strains to colonize the anterior nares. Moreover, our competitive in vivo nasal colonization
study showed that there was a trend that atl SA strains survived 10 days more than the wild-
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type strains. This might be probably due to the increased resistance of atl SA strains when
compared to wild-type.
In conclusion, our data suggest that host immune response in the nasal secretion
determines the success of SA in colonizing the anterior nares. The positively correlated immune
factors in our cytokine analyses can be specifically targeted for strategies to understand the
difference in their expression level among persistent and intermittent carriers of SA. Since SA
expresses multiple adhesion with redundant functions, atl SA strains did not show any
difference in their ability colonize the anterior nares. Therefore, creation of double knockouts Atl
with other autolysins like Aaa, SceD and IsaA might highlight the importance of all the other
autolysins in human nasal colonization. Non-competitive in vivo human nasal colonization
studies combined with our previous competitive studies might be instrumental to specifically
identify the role of Atl in SA human nasal colonization.
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APPENDIX A: TABLE 1
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Table 1: Primers used in this study

Primers

Sequence (5’-3’)

Atl F

GCTGAGACGACACAAGATCAAACTAC

Atl R

TTGCGTACCCCATGGGGCCACTTT

Atltgt1F

CAAAAGGTTGATACTACACAAGT

Atltgt1R

TACTTTTGGTGTAGCTTCAGTT

Atltgt2F

CAACAAGCACTACAGCACCT

Atltgt2R

GGTGCTTTAAGTTATTTTTACGAATG

29a _IBS
29a_EBS1d
29a_EBS2
90S_IBS
90S_EBS1d
90S-EBS2
109a_IBS
109a_EBS1
d
109a_EBS2

AAAAAAGCTTATAATTATCCTTAGCAC
GCGTGTCAGTGCGCCCAGATAGGGTG
CAGATTGTACAAATGTGGTGTAACAGA
TAAGTCGTGTCACCTAACTTACCTTTCT
TTGT
TGAACGCAAGTTTCTAATTTCGATTCGT
GCTCGATAGAGGAAAGTGTCT
AAAAAAGCTTATAATTATCCTTAAATTC
CGAACATGTGCGCCCAGATAGGGTG
CAGATTGTACAAATGTGGTGATAACAG
ATAAGTCGAACATCATAACTTACCTTTC
TTTGT
TGAACGCAAGTTTCTAATTTCGGTTGAA
TTCCGATAGAGGAAAGTGTCT
AAAAAAGCTTATAATTATCCTTAGAGT
GCCACCATGTGCGCCCAGATAGGGTG
CAGATTGTACAAATGTGGTGATAACAG
ATAGTCCACCATTTTAACTTACCTTTCT
TTGT
TGAACGCAAGTTTCTAATTTCGATTCAC
TCTCGATAGAGGAAAGTGTCT
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Source/ Reference
This study
Primer was used to
sequence atl gene around
1.1 Kbp
This study
Primer used to confirm
intron insertion in D20
strain.
This study
Primer was used to
confirm the intron
insertion in D20-24 &
547-14 strain

This study
Targetron primers for
D20-24

This study
Targetron primers for
D20-24

This study
Targetron Primers for
D547-14

APPENDIX B: TABLE 2
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Table 2: Bacterial strains and plasmids
Bacterial
strains or
plasmids
D20 -1998

Description (MLST type, Spa type and Restriction
sites)
ST30, t12255 isolated from donor D20 in1998

D20-24

ST5, t688 isolated from donor D20 in

D502-9

ST106, t056 isolated from donor D502

D528-9

ST8, t008 isolated from donor D528

D547-14

ST5, t688 isolated from donor D547

D637-7

ST8, t2648 isolated from donor D637

D713-4

ST5, t548 isolated from donor D713

D720-9

ST1657, t1001 isolated from donor D720

D756-3

ST2227, t012 isolated from donor D756

D757-5

ST8, t008 isolated from donor D757

D795-7

ST15, t084 isolated from donor D795

D830
D831
DH5 E.coli

DC10B E.coli

pNL9164
plasmid

pNL9164-29a

ST2333, t12893 isolated from donor D830
ST22, t852 isolated from donor D831
E.coli competent cell used for cloning the shuttle
vector
dcm- mutant in the DH10B strain of E.coli and is
used for passaging the plasmid retargeted for
intron insertion in the SA nasal isolates and has
HindIII and BrsG1 in their multiple cloning site
Temperature sensitive shuttle vector for SA pT181
replicon: Ampr Eryr and has HindIII and BrsG1
in their multiple cloning site. Its from pcn39
vector backbone that is retargeted for Hsa gene in
SA
pNL9164 retargeted for intron insertion in D201998 nasal isolate

Sources & Reference
Refer dr.Cole’s paper
(Muthukrishnan et
al., 2013)
(Muthukrishnan et
al., 2013)
(Muthukrishnan et
al., 2013)
(Muthukrishnan et
al., 2013)
(Muthukrishnan et
al., 2013)
(Muthukrishnan et
al., 2013)
(Muthukrishnan et
al., 2013)
(Muthukrishnan et
al., 2013)
(Muthukrishnan et
al., 2013)
(Muthukrishnan et
al., 2013)
This study
This study
Invitrogen

(Monk et al., 2012)

Sigma

This study

pNL9164-90s

pNL9164 retargeted for intron insertion in D2024 nasal isolate

This study

pNL9164109a

pNL9164 retargeted for intron insertion in D547
nasal isolate

This study
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12201 Research Parkway, Suite 501
Orlando, Florida 32826-3246
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Approval of Human Research
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